MARTIN MEMMOTT: Open Payments
NPI 1972780534 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 25 payments from 6 companies in 2025. Trend: 2023 $710 · 2024 $0 · 2025 $550
Food & beverage: $443Travel & lodging: $108
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 17 | $307 |
| BIOTRONIK NRO, Inc. | 2 | $118 |
| ABBVIE INC. | 3 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Merz Pharmaceuticals, LLC | 1 | $14 |
Products named: WaveWriter Alpha Prime 16, Intracept, Prospera, QULIPTA, UBRELVY, JOURNAVX, RELISTOR, Xeomin.
Industry payments across UT — which companies pay providers there.
